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1. Introduction 
An often overlooked aspect of carbohydrate metab- 
olism is that most carbohydrates in solution are mix- 
tures of several constitutional nd configurational 
isomers (acyclic forms and anomers), each present in 
different concentrations and capable of displaying a
different affinity and reactivity for enzyme catalytic 
and allostenc sites (anomeric specificity). In this paper, 
the possibility is considered that this characteristic 
isomerism of carbohydrates might provide the basis 
for regulation of the enzymes that metabolize them, 
using the example of the phosphofructokinase/ 
fructose 1,6-bisphosphatase enzyme pair. Several 
investigators have pointed out the possibility that 
anomedc specificity may play a regulatory role [1-5] ; 
however, until now no mechanism has been proposed 
to show how this regulation may be achieved. 
The basis for the regulatory mechanism proposed 
in this communication is the recent harvest of data 
concerning the anomeric equilibria of carbohydrates 
in solution (reviewed in [6,7] ) and the anomeric 
specificity of the enzymes of glucose metabolism 
(reviewed in [2,4] ). D-Fructose 6-phosphate (F6P) 
and D-fructose 1,6-bisphosphate (FBP) have been 
shown by laC NMR spectroscopy to be equilibrated 
mixtures in aqueous olution (fig.l), composed of 
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approx. 20% ol-anomer, 80%/3-anomer, and 24% 
keto form [8-10].  The possibility that approx. I% of 
the hydrated keto form may be present has been con- 
sidered [10] but is not supported by recent work [11 ] 
as well as earlier studies [12]. The rate constants for 
the spontaneous a -+/3 anomerization of F6P and FBP 
at 25°C have been reported to be 1.6 s -1 and 0.55-8.1 
s -I, respectively [10,13,14]. 
The enzymes that act on F6P and FBP, namely 
phosphofructokinase (PFK) and fructose 1,6-bis- 
phosphatase (FBPase), have been shown to have 
reciprocal anomeric specificities for their substrates. 
Thus PFK from rabbit muscle has been shown to be 
specific for ~F6P [1,14-17], as are probably the 
enzyme from microbial sources [18,19]. FBPase 
from rabbit liver has been shown to be specific for 
~FBP [20,21]. The error in the report [22] that 
bovine liver FBPase is specific for/~FBP has been 
recently pointed out [21]. 
2. Assumptions and supporting evidence 
Along with the confirmed results mentioned above, 
we are making the following assumptions in the con- 
ception of the proposed regulatory model. Supporting 
evidence for each assumption is discussed below. 
1. The transit ime of F6P and FBP between PFK and 
FBPase in vivo is small compared to the spontane- 
ous rates of anomerization of these ketose phos- 
phates. 
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Fig. 1. Tautomeric ( yclic/acyclic) and anomeric (a- and E-cyclic) forms of D-fructose 6-phosphate and D-fructose 1,6-bisphosphate. 
. The rates of F6P phosphorylation a d/or FBP 
hydrolysis in vivo are much greater than the spon- 
taneous anomerization rates of F6P and FBP. 
. The transit ime of F6P and FBP between PFK 
and FBPase is much shorter than the transit ime 
of these sugar phosphates between the latter two 
enzymes and any enzyme with anomerase activity. 
4. PFK is inhibited by aF6P. 
5. FBPase is inhibited by/3FBP. 
6. PFK is allosterically activated by aFBP. 
7. FBPase is allosterically activated by j3F6P. 
In support of the first assumption is the evidence 
that PFK and FBPase bind specifically to each other 
in vitro [23-28] to form an enzyme complex. Based 
on this evidence, we can envision that the active-sites 
of both enzymes are as close as 100 •. Taking the 
diffusion coefficient within the enzyme complex to 
be 10 -8 cmZ/s [29], then the transit ime of F6P and 
FBP between active sites would be more than 103 
208 
times shorter than the half-life of their spontaneous 
anomerization. 
The second assumption is supported by calculations 
based on the values for the rates of spontaneous 
anomerization f F6P and FBP in vitro [t3,14] and 
the concentrations of these sugar phosphates and 
activities of PFK and FBPase in vivo [29,30]. The rates 
of anomerization reported at 25°C were arbitrarily 
multiplied by 3 to obtain the approximate rate at 
37°C. These calculations show one or both of the 
enzymatic rates to be 10-t  5-fold faster than the rates 
of ketose phosphate anomerization. Similar supporting 
calculations have been presented by Bloxham and 
York [31]. Such estimates may be conservative since 
Frey et at. [21] have suggested that the in vivo rates 
of anomerization of ketose phosphates are probably 
lower than their in vitro rates [10,13,14] because of 
enzymatic binding and sequestering of keto forms 
which are obligatory intermediates in the anomerization 
process. 
Potentially challenging the second assumption 
would be the action of anomerases (mutarotases), 
enzymes capable of catalyzing the anomerization 
process. Of the enzymes endowed with such activity', 
only two have been shown to act on F6P or FBP in 
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vitro [4]. These are yeast phosphoglucose isomerase 
(PGI) [32] and yeast aldolase (ALD) [33]. Muscle 
aldolase [13], on the other hand, lacks anomerase 
activity. Thus it would seem possible, especially in 
the case of yeast, that the anomerase activity of PGI 
or ALD would invalidate assumption number two. 
However, this would only be true if PGI and ALD 
were a part of the PFK-FBPase complex. It is for 
this reason that assumption number three is advanced 
and supported. 
In support of the third assumption is the evidence 
that PFK and FBPase exist together in an enzyme 
complex (vide supra) and that other enzymes, 
including aldolase, show no evidence of participation 
in this complex [28]. A recent study [34] on the 
adsorption of skeletal muscle glycolytic enzymes onto 
muscle structural proteins revealed PFK to be almost 
completely bound, whereas PGI and ALD to have 
much lower affinities as well as different responses to 
the presence of calcium. Unfortunately, the FBPase 
affinity or its effect on PFK activity were not reported 
in that system. 
Based on the above findings, which are probably 
true for most eukaryotic ells, one can assume the 
PFK-FBPase complex is adsorbed onto a surface in 
vivo. As such the enzyme pair becomes analogous to 
immobilized, coupled enzymes. In such immobilized 
systems there is ample evidence [29] that substrate 
and product concentrations within the boundary of 
the adsorbed complex are maintained.at  level far 
from their equilibrium concentrations outside the 
boundary (e.g., in the cytosol). Thus, even if one 
assumes that PGI and ALD do have anomerase activity 
in vivo, they would have negligible ffect on the 
anomerization of F6P and FBP inside the complex 
as long as they are not components hereof. 
The fourth assumption is supported by the finding 
that 2,5-anhydro-D-glucitol 6-phosphate, an analogue 
of aF6P, is a good inhibitor of PFK [ 1,18]. Similarly, 
the fifth and sixth assumptions are supported by the 
findings that analogues of t3FBP are inhibitors of 
FBPase and those of aFBP are activators of PFK 
[4,35,36]. 
Additional evidence supporting the sixth assump- 
tion is the recent study of the mechanism of activation 
of PFK [37] by FBP. If the enzyme is activated by 
aFBP only, its activation rate should equal the spon- 
taneous rate of anomerization of/3 ~ a FBP since PFK 
produces ~FBP only. The finding [37] that the half- 
life for FBP-mediated activation of PFK is approx. 
0.4 s at 25°C is remarkably similar to the half-life of 
the/3 ~ o~ anomerization of FBP (0.43 s [10] ). 
The seventh assumption has yet to be experimentally 
tested. Experiments, in our laboratory, are underway 
to verify this assumption. Finally, it should be noted 
that assumptions umber 6 and 7 are not essential for 
the operation of the proposed model; however they 
allow it to function at an even higher level of efficiency. 
3. The model (fig.2) 
It is proposed that the anomeric specificities of 
PFK and FBPase create a nonequilibrium distribution 
of the anomers of F6P and FBP in the PFK-FBPase 
complex. This anomeric nonequilibrium acts as a 
signal for the rapid communication of information 
between the two enzymes. It is further proposed that 
the anomeric specificity of the catalytic and allosteric 
sites of PFK and FBPase renders them signal receivers 
for thisinformation and acts to coordinate their acti- 
vities. The basis for anomeric signal reception at the 
catalytic sites is the competitive inhibition of one 
enzyme by the product of the other. The basis of 
modulation at the allosteric sites is the activation of one 
enzyme by the substrate of the other. 
The result of this anomeric signaling and receiving 
is an antagonism of the activity of one enzyme with 
respect o the other. This antagonism of activity 
constitutes a substrate-level r gulation that acts to: 
(i) Inhibit futile cycling. 
(ii) Amplify the stimulation or inhibition of each 
enzyme of the pair by its allosteric modulators, 
such as AMP and citrate, thus enhancing the 
behavior of this enzyme pair as an electronic fl ip- 
flop device. 
(iii) Coordinate optimally the activities of PFK and 
FBPase with other glycolytic enzymes uch as 
pyruvate kinase if these other enzymes exist in 
the same complex as PFK and FBPase. 
The corollaries described below follow from the appli- 
cation of this model. 
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Fig.2. Proposed mechanism for the regulation of phosphofructokinase and fructose 1,6-bisphosphatase ctivities through reciprocal 
anomeric specificities at their catalytic and aUosteric sites. 
Corollary 1 
External stimulation of PFK (e.g., by AMP or a 
pulse of/3F6P) leads to decreased activity of FBPase 
by: 
(i) Competitive inhibition at the FBPase catalytic 
site by/~FBP. 
(ii) Utilization of/3F6P, the allosteric activator of 
FBPase. 
Stimulation of PFK is enhanced by a decrease in con- 
centration of its catalytic inhibitor aF6P. 
Corollary 2 
External stimulation of  FBPase (e.g., by citrate or 
a pulse of ctFBP) leads to decreased activity of PFK by: 
(i) Competitive inhibition at the PFK catalytic site 
by aF6P. 
(ii) Utilization of aFBP, the allosteric activator of 
PFK. 
Stimulation of FBPase is enhanced by decrease in 
concentration of its catalytic inhibitor/3FBP. 
Corollaries 3 and 4 
External inhibition of PFK (e.g., by citrate) or 
external inhibition of FBPase (e.g., by AMP) leads to 
activation of the antagonistic enzyme by elimination 
of competitive inhibition at its catalytic site and 
increased production of its allosteric activator. 
Corollaries 5 and 6 
When neither enzyme is stimulated or both are 
equally stimulated, the anomeric equilibria of their 
substrates and products tend to inhibit both enzymes. 
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4. Further evidence for the model and its amplification of PFK activity (fig.2). 
Our proposal that anomeric specificities of PFK 
and FBPase can produce a nonequilibrium distribu- 
tion of the anomers of F6P and FBP is supported by 
a computer simulation study [38] based on the in 
vitro measurements of anomer concentrations and 
anomerization rates [8-10,13,14] corrected to 
37°C, and in vivo measurements of F6P and FBP con- 
centrations as well as PFK and FBPase activities 
[29,30]. In this study, we [38] have shown that the 
extent of perturbation from anomeric equilibrium is 
dependent on the activities of PFK and FBPase as 
well as the total amount of fructose phosphate pres- 
ent in the system. For example, in rat liver (pH 7.4, 
37°C), for which PFK activity is 3.3 #mol/min/g wet 
wt and FBPase activity 15 #mol/min/g wet wt [30] 
and the total equilibrated fructose phosphate 40 nmol/ 
g wet wt [29], the/3/a ratio is 2.2 for F6P and 86 for FBP, 
instead of the equilibrium ratio of 4.0 [9]. The experi- 
mental confirmation of the results of these simula- 
tions has to await the surmounting of certain technical 
difficulties. 
The reciprocal anomeric specificities of PFK and 
FBPase that lead to the proposed antagonism of the 
two enzyme activities (fig.2) is consistent with the 
reciprocal activator-inhibitor relationships of the 
extensive list of allosteric modulators of the two 
enzymes [39,40] as well as the reciprocal oscillatory 
behavior of F6P and FBP [41]. 
As to whether the proposed mechanism (fig.2) is 
indeed operative in vivo, we can state that the effects 
expected to result from anomeric regulation are con- 
sistent with the experimental data. For example: 
1. A pulse of/3FBP, produced by stimulation of PFK, 
serves to coordinate optimally the activity of that 
enzyme with those of aldolase and pyruvate kinase; 
since aldolase requires/3FBP as substrate [13,33,42] 
and pyruvate kinase requires it as aUosteric acti- 
vator [3]. 
2. The presence of FBPase in skeletal muscle does 
enhance the stimulatory effect of AMP on PFK 
[43]. We would explain this observation, however, 
not in terms of the effects of futile cycling as 
proposed [43], but in terms of the anomeric 
non-equilibrium state of the fructose phosphates 
3. Our model is consistent with the observation that 
low levels of FBP both prevent as well as reverse the 
inactivation of PFK by FBPase [28]. 
Finally, significant futile cycling remainsto be 
established [44,45]. The isotope studies consistent 
with high levels of futile cycling [46] have recently 
been given other explanations [44,45,47--49]. 
5. Significance of the model 
Previously, nucleotides such as ATP, AMP, and 
cAMP as well as other metabolites such as citrate and 
oleate have been shown to exert a reciprocal regula- 
tion at the allosteric sites of PFK and FBPase. We 
have shown that the anomeric specificities of these 
enzymes may serve as the basis for a similar reciprocal 
regulation at both the catalytic and allosteric sites. 
Such a regulation would be another example of the 
kind of efficient, self-regulatory mechanism charac- 
teristic of the living state. 
It is of interest o assess the contribution of the 
proposed anomeric regulation to the total modulation 
of PFK and FBPase activities. Computer simulations 
[38] show that futile cycling by these enzymes may 
be reduced to levels as low as 37% of those without 
the inclusion of anomeric regulation. These studies 
not withstanding, it seems likely that anomeric regula- 
tion must play a role secondary to the regulation by 
nucleotides and the other allosteric effectors. How- 
ever, it is conceivable that, prior to the evolution of 
allosteric sites, the proposed anomeric regulation pro- 
vided a mechanism for the suppression of futile cycling 
Finally, it should be noted that the proposed ano- 
meric regulation might be operative at other antago- 
nistic enzyme pairs (e.g., glucokinase/glucose 6-phos- 
phatase). 
6. Conclusions 
In summary, we have proposed amodel (fig.2) 
for the anomeric regulation of phosphofructokinase 
and fructose 1,6-bisphosphatase in which each enzyme 
is allosterically activated by the substrate, and com- 
petitively inhibited by the product of the other (phos- 
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phofructokinase acts on and produces the/3-forms 
whereas fructose 1,6-bisphosphatase acts on and pro- 
duces the a-forms of the fructose phosphates). The 
proposed mechanism enhances the action of this 
enzyme pair as a 'metabolic f l ip-f lop regulatory 
mechanism', thus suppressing futile cycling. It is 
supposed to operate simultaneously with other known 
modulators of these two enzymes (e.g., adenine 
nucleotides, citrate) and might have played a more 
important role prior to the evolution of the allosteric 
sites of these ligands. The model provides an alterna- 
tive explanation for the results of many studies of the 
two enzymes in vitro and in vivo. 
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